Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04173507
Title Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Southwest Oncology Group

lung non-small cell carcinoma

adenosquamous lung carcinoma

lung non-squamous non-small cell carcinoma


Avelumab + Talazoparib

Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.